EMPATECH MET 5/500 combines Empagliflozin 5mg (an SGLT2 inhibitor) and Metformin Hydrochloride 500mg (a biguanide) to deliver comprehensive control of Type 2 Diabetes Mellitus. This synergistic formulation not only regulates blood glucose levels but also enhances insulin sensitivity while minimizing diabetes-related health risks. Key Therapeutic Advantages Enhanced Glycemic Control – Effectively reduces HbA1c levels and maintains optimal blood sugar stability Metabolic Benefits – Promotes weight management through urinary glucose excretion Cardioprotective Action – Empagliflozin component significantly lowers cardiovascular risks Improved Insulin Utilization – Metformin optimizes the body's response to insulin Reduced Hypoglycemia Risk – Achieves glucose control without dangerous blood sugar crashes Mechanism of Action Empagliflozin (5mg): • Selectively inhibits SGLT2 renal transporters • Prevents glucose reabsorption in kidneys • Promotes elimination of excess glucose through urine (≈200-300 kcal/day loss) Metformin (500mg): • Suppresses hepatic glucose production • Enhances peripheral insulin sensitivity • Improves cellular glucose uptake Combined Effect: This dual mechanism provides superior glycemic management while addressing multiple pathological aspects of Type 2 Diabetes. Dosage & Administration Guidelines Recommended Use: • Take once or twice daily with meals (as prescribed) • Swallow tablet whole with water Important Precautions: • Maintain regular meal schedules • Avoid excessive alcohol consumption • Monitor kidney function periodically • Report any unusual muscle pain or breathing difficulties immediately Potential Adverse Effects Common (Manageable) Effects: • Increased urination (osmotic diuresis) • Transient gastrointestinal discomfort (nausea/diarrhea) • Mild dizziness (especially during therapy initiation) Serious (Require Medical Attention): • Symptoms of lactic acidosis (rare but critical) • Severe UTIs or genital mycotic infections • Persistent vomiting or dehydration signs Why Choose EMPATECH MET 5/500? This combination therapy offers three-dimensional diabetes management: 1. Glucose Regulation – Dual-pathway control 2. Organ Protection – Cardiovascular & renal benefits 3. Metabolic Improvement – Weight optimization & insulin sensitization Always used under medical supervision and in conjunction with lifestyle modifications for optimal therapeutic outcomes.
| Active Ingredient | Empagliflozin 5 mg and Metformin Hydrochloride 500 mg |
| Brand Name | EMPATECH MET 5/500 |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Package SIZE | 10x10 Tablets |
| Dosage | As Directed By the Physician |
| Storage | Store In A Cool & Dry Place |
| Country of origin | INDIA |